![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Cpa4 | Rat | 17beta-estradiol | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of CPA4 mRNA | CTD | PMID:30165855 | Cpa4 | Rat | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CPA4 mRNA | CTD | PMID:35192832 | Cpa4 | Rat | 2,2',5,5'-tetrachlorobiphenyl | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:36804509 | Cpa4 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CPA4 mRNA | CTD | PMID:32277265 | Cpa4 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of CPA4 mRNA | CTD | PMID:30851411 | Cpa4 | Rat | 5-fluorouracil | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Fluorouracil results in decreased expression of CPA4 mRNA | CTD | PMID:16510598 | Cpa4 | Rat | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of CPA4 mRNA | CTD | PMID:28959563 | Cpa4 | Rat | actinomycin D | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of CPA4 protein | CTD | PMID:38460933 | Cpa4 | Rat | aflatoxin B1 | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of CPA4 mRNA | CTD | PMID:22100608 | Cpa4 | Rat | all-trans-retinoic acid | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CPA4 mRNA | CTD | PMID:23830798 | Cpa4 | Rat | Archazolid B | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | archazolid B results in increased expression of CPA4 mRNA | CTD | PMID:25218289 | Cpa4 | Rat | aristolochic acid A | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of CPA4 mRNA | CTD | PMID:33212167 | Cpa4 | Rat | arsane | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CPA4 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CPA4 mRNA | CTD | PMID:39836092 | Cpa4 | Rat | arsenic atom | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CPA4 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of CPA4 mRNA | CTD | PMID:39836092 | Cpa4 | Rat | arsenite(3-) | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | arsenite results in decreased expression of CPA4 mRNA | CTD | PMID:23974009 | Cpa4 | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of CPA4 gene | CTD | PMID:35440735 | Cpa4 | Rat | benzo[a]pyrene | decreases expression | ISO | Cpa4 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CPA4 mRNA | CTD | PMID:22228805 | Cpa4 | Rat | benzo[a]pyrene | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CPA4 mRNA | CTD | PMID:32234424 | Cpa4 | Rat | benzo[a]pyrene | decreases methylation | ISO | CPA4 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of CPA4 3' UTR | CTD | PMID:27901495 | Cpa4 | Rat | benzo[a]pyrene diol epoxide I | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:20382639 | Cpa4 | Rat | bis(2-chloroethyl) sulfide | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Mustard Gas results in increased expression of CPA4 mRNA | CTD | PMID:25102026 | Cpa4 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CPA4 mRNA | CTD | PMID:25181051 more ... | Cpa4 | Rat | bisphenol A | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CPA4 mRNA and bisphenol A results in decreased expression of CPA4 protein | CTD | PMID:29275510 and PMID:32981897 | Cpa4 | Rat | bisphenol A | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of CPA4 mRNA | CTD | PMID:27685785 | Cpa4 | Rat | butan-1-ol | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CPA4 mRNA | CTD | PMID:29432896 | Cpa4 | Rat | butanal | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of CPA4 mRNA | CTD | PMID:26079696 | Cpa4 | Rat | cadmium atom | affects expression | ISO | CPA4 (Homo sapiens) | 6480464 | Cadmium affects the expression of CPA4 mRNA | CTD | PMID:31082282 | Cpa4 | Rat | cadmium atom | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Cadmium results in increased expression of CPA4 mRNA | CTD | PMID:35955783 | Cpa4 | Rat | cadmium dichloride | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of CPA4 mRNA | CTD | PMID:38382870 and PMID:38568856 | Cpa4 | Rat | calcitriol | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of CPA4 mRNA | CTD | PMID:16002434 | Cpa4 | Rat | camptothecin | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Camptothecin results in increased expression of CPA4 mRNA | CTD | PMID:38460933 | Cpa4 | Rat | CGP 52608 | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CPA4 gene] | CTD | PMID:28238834 | Cpa4 | Rat | cisplatin | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of CPA4 mRNA | CTD | PMID:27392435 | Cpa4 | Rat | cisplatin | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of CPA4 mRNA | CTD | PMID:27392435 | Cpa4 | Rat | cobalt dichloride | decreases secretion | ISO | CPA4 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased secretion of CPA4 protein | CTD | PMID:22079246 | Cpa4 | Rat | copper atom | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of CPA4 mRNA | CTD | PMID:20971185 | Cpa4 | Rat | copper(0) | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of CPA4 mRNA | CTD | PMID:20971185 | Cpa4 | Rat | cyclosporin A | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CPA4 mRNA | CTD | PMID:27989131 | Cpa4 | Rat | Didecyldimethylammonium | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | didecyldimethylammonium results in decreased expression of CPA4 mRNA | CTD | PMID:32763356 | Cpa4 | Rat | diethylstilbestrol | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Diethylstilbestrol results in increased expression of CPA4 mRNA | CTD | PMID:36621641 | Cpa4 | Rat | ethanol | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CPA4 mRNA | CTD | PMID:29432896 | Cpa4 | Rat | hydrogen peroxide | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Hydrogen Peroxide results in increased expression of CPA4 mRNA | CTD | PMID:32949572 | Cpa4 | Rat | isobutanol | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CPA4 mRNA | CTD | PMID:29432896 | Cpa4 | Rat | lipopolysaccharide | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CPA4 mRNA | CTD | PMID:35811015 | Cpa4 | Rat | manganese atom | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CPA4 mRNA | CTD | PMID:39836092 | Cpa4 | Rat | manganese(0) | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CPA4 mRNA | CTD | PMID:39836092 | Cpa4 | Rat | manganese(II) chloride | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CPA4 mRNA | CTD | PMID:39836092 | Cpa4 | Rat | mono(2-ethylhexyl) phthalate | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of CPA4 mRNA | CTD | PMID:36695872 | Cpa4 | Rat | N,N-diethyl-m-toluamide | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of CPA4 gene | CTD | PMID:33148267 | Cpa4 | Rat | Nutlin-3 | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased secretion of CPA4 protein | CTD | PMID:38460933 | Cpa4 | Rat | O-methyleugenol | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | methyleugenol results in increased expression of CPA4 mRNA | CTD | PMID:32234424 | Cpa4 | Rat | palbociclib | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | palbociclib results in increased expression of CPA4 mRNA | CTD | PMID:22869556 | Cpa4 | Rat | paracetamol | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of CPA4 mRNA | CTD | PMID:29067470 | Cpa4 | Rat | paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of CPA4 mRNA | CTD | PMID:32680482 | Cpa4 | Rat | pentanal | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | pentanal results in increased expression of CPA4 mRNA | CTD | PMID:26079696 | Cpa4 | Rat | permethrin | multiple interactions | EXP | | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of CPA4 gene | CTD | PMID:33148267 | Cpa4 | Rat | propanal | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of CPA4 mRNA | CTD | PMID:26079696 | Cpa4 | Rat | rac-lactic acid | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of CPA4 mRNA | CTD | PMID:30851411 | Cpa4 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CPA4 mRNA | CTD | PMID:35811015 | Cpa4 | Rat | silicon dioxide | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of CPA4 mRNA | CTD | PMID:25895662 | Cpa4 | Rat | silicon dioxide | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of CPA4 mRNA | CTD | PMID:23806026 | Cpa4 | Rat | sodium arsenite | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of CPA4 mRNA more ... | CTD | PMID:33939924 and PMID:39836092 | Cpa4 | Rat | sodium arsenite | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of CPA4 mRNA | CTD | PMID:35954277 and PMID:38568856 | Cpa4 | Rat | sodium arsenite | decreases expression | ISO | Cpa4 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of CPA4 mRNA | CTD | PMID:36209798 | Cpa4 | Rat | succimer | multiple interactions | ISO | CPA4 (Homo sapiens) | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CPA4 mRNA | CTD | PMID:26378955 | Cpa4 | Rat | sulforaphane | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | sulforaphane results in decreased expression of CPA4 mRNA | CTD | PMID:31838189 | Cpa4 | Rat | sunitinib | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of CPA4 mRNA | CTD | PMID:31533062 | Cpa4 | Rat | triclosan | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of CPA4 mRNA | CTD | PMID:30510588 | Cpa4 | Rat | tunicamycin | increases expression | ISO | Cpa4 (Mus musculus) | 6480464 | Tunicamycin results in increased expression of CPA4 mRNA | CTD | PMID:17127020 | Cpa4 | Rat | valproic acid | increases expression | ISO | CPA4 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CPA4 mRNA | CTD | PMID:28001369 | Cpa4 | Rat | zoledronic acid | decreases expression | ISO | CPA4 (Homo sapiens) | 6480464 | zoledronic acid results in decreased expression of CPA4 mRNA | CTD | PMID:24714768 | |